Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
Acute Effects of Cold Exposure on Cardiovascular System
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT06652425
- Locations
- 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China
CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRC
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 124
- Registration Number
- NCT06652412
Acute Effects of Low Temperature Exposure on Respiratory System
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 40
- Registration Number
- NCT06652932
- Locations
- 🇨🇳
Department of Environmental Health, School of Public Health, Fudan University, Shanghai, Shanghai, China
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
- First Posted Date
- 2024-10-18
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT06649331
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
AI-based Skeleton Recognition System for Rehabilitation Exercise in Breast Cancer Survivors: A Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 80
- Registration Number
- NCT06642948
- Locations
- 🇨🇳
Shanghai Cancer Center, Shanghai, China
All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancer：a Multi-center, Multi-cohort Phase II Trial
Phase 2
Recruiting
- Conditions
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 129
- Registration Number
- NCT06636981
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
Phase 3
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-11
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 1388
- Registration Number
- NCT06637150
- Locations
- 🇨🇳
breast cancer institute of Fudan University Cancer Hospital, shanghai, shanghai, Shanghai, China
Segmentectomy for Solid-dominant Lung Cancer
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 277
- Registration Number
- NCT06634966
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer
Not Applicable
Recruiting
- Conditions
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 14
- Registration Number
- NCT06636591
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
The Safety and Efficacy of Multimodal Thermal Therapy in the Treatment of Early-stage Invasive Breast Cancer
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-10-10
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT06635096
- Locations
- 🇨🇳
Breast cancer institute of Fudan University Cancer Hospital, Shanghai, Shanghai, China
© Copyright 2024. All Rights Reserved by MedPath